Physician profile
Michele Chen
NPI 1073809307
$4,666.18
in general payments reported to CMS, 2019-2025
29 companies · $964 in 2025
The $964 reported for 2025 was more than what 84% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,386 · 2022: $617 · 2023: $561 · 2024: $1,138 · 2025: $964.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,662.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,662.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,015.19 | 2023-2025 | Intellis Adaptivestim, Accurian, Synchromedii |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $674.66 | 2021-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $410.57 | 2021-2025 | Belbuca, Xtampza |
| Abbvie INC. | $297.23 | 2021-2022 | |
| Stryker Corporation | $289.14 | 2024-2025 | Mild Device Kit |
| Boston Scientific Corporation | $211.64 | 2021-2023 | |
| Curonix LLC | $190.53 | 2024-2025 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Foundation Fusion Solutions, LLC | $184.35 | 2024-2025 | |
| Nalu Medical, INC. | $180.02 | 2022-2023 | Nalu Neurostimulation System |
| Horizon Therapeutics Plc | $173.37 | 2021-2022 | |
| Spinal Simplicity, LLC | $162.64 | 2025 | Ha Minuteman G3-R |
| Scilex Pharmaceuticals INC. | $132.86 | 2021-2025 | Ztlido |
| Uswm, LLC | $131.81 | 2021-2022 | |
| Vertos Medical, INC. | $127.69 | 2024 | Mild Device Kit |
| Almatica Pharma LLC | $106.88 | 2021 |
Show all 29 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Redhill Biopharma INC. | $53.68 | 2021 | |
| Biodelivery Sciences International, INC. | $47.99 | 2021 | |
| Pfizer INC. | $34.24 | 2021 | |
| Allergan, INC. | $32.97 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $32.76 | 2025 | |
| Radius Health, INC. | $30.90 | 2021 | |
| Novartis Pharmaceuticals Corporation | $30.00 | 2021 | |
| Lilly USA, LLC | $26.42 | 2021 | |
| Stimwave Technologies Incorporated | $17.15 | 2021 | |
| Neuronetics, INC. | $15.90 | 2022 | |
| Arbor Pharmaceuticals, INC. | $15.71 | 2021 | |
| Baudax Bio INC. | $14.23 | 2021 | |
| Virtus Pharmaceuticals LLC | $13.38 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $12.27 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michele Chen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.